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Abstract
Background: Dizziness is a frequently reported symptom in older people that can markedly impair quality of life.
This manuscript presents the protocol for a randomised controlled trial, which has the main objective of determining
the impact of comprehensive assessment followed by a tailored multifaceted intervention in reducing dizziness
episodes and symptoms, improving associated impairments to balance and gait and enhancing quality of life in
older people with self-reported significant dizziness.
Methods: Three hundred people aged 50 years or older, reporting significant dizziness in the past year will be
recruited to participate in the trial. Participants allocated to the intervention group will receive a tailored, multifaceted
intervention aimed at treating their dizziness symptoms over a 6 month trial period. Control participants will receive
usual care. The primary outcome measures will be the frequency and duration of dizziness episodes, dizziness symptoms
assessed with the Dizziness Handicap Inventory, choice-stepping reaction time and step time variability. Secondary
outcomes will include health-related quality of life measures, depression and anxiety symptoms, concern about falling,
balance and risk of falls assessed with the physiological fall risk assessment. Analyses will be by intention-to-treat.
Discussion: The study will determine the effectiveness of comprehensive assessment, combined with a tailored,
multifaceted intervention on dizziness episodes and symptoms, balance and gait control and quality of life in
older people experiencing dizziness. Clinical implications will be evident for the older population for the diagnosis and
treatment of dizziness.
Trial registration: The study is registered with the Australia New Zealand Clinical Trials Registry
ACTRN12612000379819.
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Background
Dizziness is a frequent complaint of older people. Current
or chronic symptoms of dizziness are reported by 10%
[1, 2] to 30% [3, 4] of community-dwelling older adults
with an increasing prevalence as people age [1, 3, 5].
Dizziness markedly impairs quality of life [6], and is
associated with a two-fold increase in the prevalence of
self-reported functional disability [1], worsening of
depressive symptoms [2, 4], decreased participation in
social activities, poor self-reported health and reduced
falls self-efficacy [4]. There is also evidence of a rela-
tionship between acute dizziness and falls [3, 7] and the
frequency of dizziness episodes is associated with dis-
ability [1], falls and syncopal events [7].
Dizziness is a subjective sensation that is used to de-
scribe feelings such as light-headedness, feeling faint,
head spinning, room spinning, unsteadiness, and feeling
woozy or giddy. Clinically, dizziness is described as a
feeling of altered orientation in space [8]. Traditionally,
it has been divided into four main subtypes [9, 10]: (i)
vertigo, where patients express illusory sensation of self-
motion which often is the result of a vestibular system
disorder; (ii) presyncopal dizziness, a light-headed sensa-
tion associated with cerebral hypoperfusion; (iii) psycho-
genic dizziness, associated with a mental health issue
such as generalised anxiety; and (iv) disequilibrium and
non-specific dizziness, often associated with neuromus-
cular causes. In older people, dizziness may have a
multifactorial aetiology, with many dizzy older patients
fulfilling criteria for two or more of the subtypes de-
scribed above [11–13].
This multifactorial aetiology [11–14] combined with im-
precise symptom descriptions [15], make it difficult to es-
tablish an accurate diagnosis of dizziness [16, 17] A
retrospective chart audit of 50 older patients with dizzi-
ness from a family practice showed that 45% did not have
a diagnosis and 10% had more than one diagnosis [16].
Furthermore, in 20% of consecutive older patients pre-
senting to a general practice, there was no attributable
cause of dizziness based on clinical characteristics [17].
Other contributing factors to the diagnostic challenge of
dizziness include overreliance on symptom description to
establish a diagnosis [18], a tendency to diagnose condi-
tions in the clinicians own field of experience (“the blind
men and the elephant” phenomenon) [19], and the lack of
diagnostic accuracy of many tests [20].
If an accurate diagnosis for the underlying cause of
dizziness can be made, there is potential for effective
therapy. The Epley manoeuvre and vestibular rehabilita-
tion appear effective in managing Benign Paroxysmal Pos-
itional Vertigo (BPPV) [21] and some unilateral peripheral
disorders [22], respectively. There are also well-established
syncope assessment and management guidelines [23], fall
prevention balance and strength exercise programs for
older people [24, 25], and emerging cognitive behav-
ioural therapies (CBT) that could be readily applied to
older patients with psychogenic dizziness [26].
A comprehensive multidisciplinary assessment of diz-
ziness holds great promise for more effectively diagnos-
ing and treating dizziness in older people. There have
been models proposed before and these have had some
success in reducing the number of unresolved cases
[5, 9, 13, 14, 27, 28]. However, these assessments are
either very time consuming [9], have never been fur-
ther developed as tools [13, 27], or are not based on
empirical evidence [14, 27, 28]. A one-stop dizziness
assessment would be welcomed by older people with
dizziness who report that they would like to minimize
the number of specialist referrals, for logistical rea-
sons, cost and because they perceive that specialist’s
consultations often do not result in successful treat-
ment [29].
This randomised controlled trial will aim to improve the
understanding of dizziness, its assessment and its manage-
ment in older people, overcoming the barriers we have
described. We have designed a comprehensive, multidis-
ciplinary battery of vestibular, cardiovascular, neuromus-
cular, balance and psychological assessments to improve
the likelihood of obtaining a diagnosis for the symptom of
dizziness in middle-aged and older people.
Primary objective
To compare the effect of a tailored multifaceted inter-
vention with usual care on frequency of dizziness epi-
sodes, balance and gait performance and quality of life
in people aged 50 years and over with self-reported sig-
nificant dizziness.
Secondary objectives
 To establish the cost-effectiveness of the program
from the health provider’s perspective.
 To determining the effects of the program on
vestibular, cardiovascular and psychological
measures associated with dizziness.
Methods
Design
A single blind parallel group randomised controlled trial
will be conducted in 300 participants with dizziness.
Figure 1 presents the study flow diagram. The Human
Research Ethics Committee of the University of New
South Wales approved this study (HC 12152). The study
is registered with the Australia New Zealand Clinical
Trials Registry (ACTRN12612000379819) (Table 1).
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Participants
People aged 50 years or older, living in the community will
be recruited through advertisements; flyers on community
facilities, hospital and university noticeboards; articles in
newspapers and newsletters for older people; the Neuro-
science Research Australia (NeuRA) website, newsletter
and mailing list; and by mail box drops within the local
community and retirement villages. To be eligible for the
study, participants must: (i) be aged 50 years and over; (ii)
have experienced at least one significant episode of dizzi-
ness in the past 12 months; (iii) live independently in the
community or retirement village and; (iv) be able to
understand English. Data will be collected in Australia.
People will be ineligible to participate in the study if
they; (i) have a degenerative neurological condition; (ii)
are currently receiving treatment for their dizziness; (iii)
have a cognitive impairment (a General Practitioner As-
sessment of Cognition (GPCOG) of <5) [30] and/or; (iv)
are unable to walk 20 m without difficulty with the use
of a walking aid.
Participants identified on assessment with conditions
that require urgent treatment defined as suspected
stroke, transient ischemic attack or other undiagnosed
neurological or acute cardiovascular condition, severe
depressive or anxiety symptoms will also be excluded
from the study and referred following consent for appro-
priate treatment.
Baseline assessment and case conference
All eligible participants will attend NeuRA for a three-hour
baseline assessment undertaken by trained research
assistants. The study will be explained in detail and written
consent obtained prior to commencing the assessment.
The assessments are outlined in Table 2. These include
diagnostic tests for descriptive purposes and for allocating
intervention participants to treatment arms as well as base-
line measures for the primary and secondary outcomes.
A multidisciplinary case conference will then be held
within two weeks of the assessment to reach a consensus
diagnosis and design a tailored intervention plan based
on the baseline assessment results. Results of all assess-
ments undertaken will be reported and recommenda-
tions regarding appropriate therapies derived and
prioritised. Panel members will include at least a geria-
trician, a vestibular neuroscientist, an exercise physiolo-
gist and a baseline assessor.
Randomisation
After completion of the baseline assessment and case
conference, participants will be randomised into inter-
vention or control groups. Permuted blocks (sizes: 2, 4
and 6) using a computer generated random number
schedule will be performed to determine randomisation
order. Allocation will be concealed by using central ran-
domisation performed by NeuRA personnel not other-
wise involved in the study. Staff performing outcome
measurement and data analysis for the primary out-
comes will be blinded to group allocation. However, due
to the nature of the intervention, it is not possible to
blind the staff administering interventions or the partici-
pants. Participants will be instructed not to inform the
assessors of their intervention status.
Fig. 1 Study flow diagram
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Table 1 Trial registration data from the World Health Organization Trial Registration Data Set
Data category Information
Primary registry and trial identifying number anzctr.org.au
ACTRN12612000379819
Date of registration in primary registry 3 April 2012
Secondary identifying numbers N/A
Source(s) of monetary or material support Australian National Health and Medical Research Council
Primary sponsor Professor Stephen Lord, Neuroscience Research Australia
Secondary sponsor Dr Jasmine Menant, Neuroscience Research Australia
Contact for public queries Professor Stephen Lord, DSc [S.Lord@neura.edu.au]
Contact for scientific queries Professor Stephen Lord, DSc
Neuroscience Research Australia, Randwick Sydney, Australia
Public title Treating dizziness in older people
Scientific title A randomised controlled trial of dizziness interventions based
on a multidisciplinary assessment in older people: towards the
development of a multiple profile assessment of dizziness – the MPA-D
Countries of recruitment Australia
Health condition(s) or problem(s) studied Dizziness in older people
Intervention(s) Active comparator: Multifaceted tailored intervention including a home
exercise program, a vestibular rehabilitation program, a booklet-based
cognitive behavioural therapy, and/or a comprehensive geriatric
assessment and medication review.
Placebo comparator: usual care, no intervention
Key inclusion and exclusion criteria Ages eligible for study: ≥50 years
Sexes eligible for study: both
Accepts healthy volunteers: yes
Inclusion criteria: adult patient (≥50 years), having experienced one or more
episode(s) of dizziness in the past year and not being currently treated for it;
living independently in the community or retirement village; able to
understand English.
Exclusion criteria: presence of a diagnosed degenerative neurological condition
or severe cognitive impairment (GP-Cog score equal or below 4).
Study type Interventional
Allocation: randomized intervention model. Parallel assignment masking:
single blind (investigator, outcomes assessor)
Primary purpose: prevention
Phase III
Date of first enrolment August 2012
Target sample size 300
Recruitment status Completed
Primary outcome(s) • Frequency and duration of dizziness episodes experienced in the 6-months
period between baseline and re-test.
• Dizziness-related quality of life recorded using a validated questionnaire,
the Dizziness Handicap Inventory
• Choice stepping reaction time: a composite measure of reaction time,
strength and balance.
Time points for all outcomes: baseline and 6 months post-baseline
(i-e at the end of the intervention period)
Key secondary outcomes • Tilt table test of orthostatic hypotension
• Coordinated Stability - a test of leaning balance
• Geriatric depression scale - 15 items: a questionnaire to assess
depression disorders
Time points for all outcomes: baseline and 6 months post-baseline
(i-e at the end of the intervention period)
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The intervention
Based on their underlying conditions and case confer-
ence recommendations, appropriate interventions will
be organised for participants assigned to the interven-
tion group (Table 3). The intervention plan will be
guided by published normative data for the vision, sen-
sorimotor, balance and psychological tests and the
presence of abnormal results in our vestibular and car-
diovascular tests. Due to the multifactorial aetiology of
dizziness in older people, it is likely that many partici-
pants will require multiple interventions which we will
implement in a staged manner.
Adverse events (for example, a fall during an exercise ses-
sion) will be monitored with monthly calendars and tele-
phone calls as required and adherence to all interventions
documented with therapist records and/or participant diaries.
A trial safety committee composed of two Senior staff
of Neuroscience Research Australia (a Senior scientist
and a Senior biostatistician), not involved in any aspect
of the study and independent from the sponsor and
investigators, will review the withdrawal, deceased and
incident data of the trial annually and report to the
Ethics Committee.
The control group
Control group participants will receive usual care dur-
ing the six-month trial period. At completion of the
trial, they will be provided with their baseline and re-
assessment reports and given the option to being re-
ferred appropriate therapies.
Primary and secondary outcomes
The primary outcome measures outlined in Table 2 will
capture the four crucial aspects of the trial: dizziness, bal-
ance, walking stability and quality of life. The secondary
outcome measures, also outlined in Table 2, will elucidate
Table 2 Baseline assessment (BA) and re-assessment (RA) including outcome measures
Domain Test and criterion for abnormal/impaired performance BA RA O
General • Patients’ history and medications. ✓ ✓ -
• Frequency and duration of dizziness episodes. ✓ ✓a P
• Dizziness Handicap Inventory [36]. ✓ ✓ P
• Vertigo Symptom Scale [37]. ✓ ✓ S
• EQ-5D: a generic measure of health status which will be used in the economic evaluation [38]. ✓ ✓ S
• AQOL-6D (Assessment of Quality of Life): a utility measure of quality of life - will
be used to conduct the economic evaluation [39].
✓ ✓ S
Vestibular • Eye movement examination (nystagmus, pursuit, saccades, Vestibulo-Ocular Reflex (VOR) suppression)
using Frenzel’s glasses [40] – abnormalities are indicative of peripheral and/or central vestibular disorder.
✓ ✓ -
• Dix-Hallpike positional manoeuvre : a positive test indicates Benign Paroxysmal Positional Vertigo [22]. ✓ ✓ -
• Dynamic-Visual Acuity (DVA) Test – assessed during passive head impulses, score > 0.316 indicates
impaired DVA [41]
✓ ✓ -
• Video Head Impulse Test: a + test indicates impaired VOR, peripheral vestibular disorders [42–44]. ✓ ✓ -
• Rotary chair testing: VOR gain < 0.75 (at 1 Hz) and time constant < 6 s indicates VOR hypofunction,
time constant >12 s indicates cerebellum disorders [41]
✓ ✓ -
Cardio-vascular • Tilt Table test - a decrease in systolic blood pressure ≥20 mmHg or a decrease of systolic blood
pressure to ≤90 mmHg after 3 min of upright standing, defines orthostatic hypotension whether
or not symptoms occur [23, 45, 46].
✓ ✓ S
• Electrocardiogram - arrhythmia defines possible arrhythmia-related syncope [23]. ✓ - -
Balance, Gait and Fall Risk • Physiological Profile Assessment of fall risk - performances 1 standard deviation below established
norms for older people aged 65 years and over define impairments in vision, touch, peripheral sensation,
reaction time, lower limb strength and balance [47, 48].
✓ ✓ S
• Coordinated Stability - score ≥15 error points indicates impaired dynamic balance [7, 49]. ✓ ✓ S
• Choice-Stepping Reaction Time - total reaction time > 1.4 s indicates impaired performance
(composite measure of strength, balance and reaction time) [31].
✓ ✓ P
• Step timing variability at preferred walking speed > 0.03 s indicates impaired walking stability [32, 50]. ✓ ✓ P
Psychological • Falls Efficacy Scale –International - score > 22 indicates high levels of fear of falling [51, 52]. ✓ ✓ S
• Patient Health Questionnaire −9 - score > 9 indicates depressive symptoms [53–56]. ✓ ✓ S
• Generalized Anxiety Disorder 7 items scale - score > 7 indicates anxiety disorders [57]. ✓ ✓ S
• Neuroticism scale of the NEO-Five Factor Inventory– score ≥ 56 indicates a high level of neuroticism [58]. ✓ ✓ S
BA Baseline Assessment, RA Re-assessment, O Outcome measure, S secondary, P Primary
aassessed monthly throughout the six-month trial period
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how the interventions assist in ameliorating dizziness
symptoms. Dizziness episodes and duration will be ascer-
tained with monthly calendars and telephone calls as re-
quired. Participants will return to NeuRA for reassessment
of outcomes at the end of the trial (6 months post random-
isation). Staff monitoring the dizziness episodes and admin-
istering reassessments will be blinded to group allocation.
Sample size calculation
A power analysis determined that 300 participants (150
per group) will need to be recruited to provide 80% power
to detect a statistically significant 20% between-group
difference in the primary outcome measures. For these
calculations, we assumed an alpha of 0.05 and a dropout
rate of 15%. We assumed the following control group
means (standard deviations), based on values from previ-
ous studies of older people [31–33]: choice-stepping reac-
tion time = 1322 (331) ms, step-time variability = 0.02
(0.01) s, and dizziness handicap inventory = 37 (2).
Statistical analysis
All analyses will use an intention-to-treat approach and
analysis of the primary outcomes will be conducted
masked to group allocation. Dizziness episodes will be
contrasted between groups with negative binomial re-
gression due to the likely Poisson- like distribution of
this variable. Between-group comparisons of retest per-
formance for the continuously-scored primary and sec-
ondary outcome measures will be made using General
Linear Models (ANCOVA) controlling for pre-test per-
formance and other potential confounders. Estimates of
the magnitude of clinical improvement in symptoms of
anxiety and depression will be derived using calculations
of effect size (Cohen’s d) and percentage of symptom
improvement. Predictors of uptake, acceptability and ad-
herence will be established using multivariate modelling
techniques including multiple linear and logistic regres-
sion analyses. Analyses will be conducted using the SPSS
software package.
Economic analysis
An economic evaluation will be conducted from the per-
spective of the health and community service provider.
Benefits will be measured in terms of quality-adjusted
life years (QALY) gained, based on utility weights de-
rived from the EQ-5D and AQoL-6D collected at base-
line and at 6 months. The study will collect data on the
cost to deliver the intervention program. Using the mean
costs in each trial arm, and the mean health outcomes
in each arm, the incremental cost per QALY of the inter-
vention group compared to control groups will be calcu-
lated and results plotted on a cost-effectiveness plane.
Bootstrap sampling will be used to estimate a distribu-
tion around costs and health outcomes, and to calculate
the confidence intervals around the incremental cost-
effectiveness ratio. We will conduct a one-way sensitivity
analysis and a probabilistic sensitivity analysis to esti-
mate the joint uncertainty in cost and effect parameters.
Table 3 Underlying conditions diagnosed and indicated interventions
Underlying condition Intervention
Benign Paroxysmal Positional Vertigo Epley’s manoeuvre [22]: repositioning manoeuvre performed on the patient by a
physiotherapist to remove vestibular debris from the semi-circular canals.
Peripheral vestibular conditions 1. Vestibular rehabilitation [22] administered by a vestibular physiotherapist.
2. Referral to an ear-nose-throat specialist or neurologist as indicated.
Central vestibular conditions 1. Onward referral to neurologist, magnetic resonance imaging scan/other scans as indicated.
2. Review at Falls Clinic by Consultant Geriatrician for management of any co-morbidities
and medication review.
Anxiety/depression/low falls efficacy 1. Online or booklet-based Cognitive Behavioural Therapy (CBT) with telephone support
to a clinical psychologist; the program will be focusing on management of anxiety,
depression and fear of falling. The booklet will have the same contents and presentation
as the internet-based CBT [59–61]; given that not all participants might have access to
internet in their home, the booklet-based CBT will ensure that all participants from the
intervention group who require a therapy addressing psychogenic dizziness will receive
the same CBT intervention. The CBT program will involve 5 lessons including a weekly
homework assignment over 8 weeks.
2. Referral to other mental health services if indicated.
Cardiovascular conditions 1. Medication management of postural hypotension [23]: the participant will be referred to
a Consultant Geriatrician’s Falls Clinic for a medication review.
2. Onward referral to cardiologist if indicated.
Balance, strength, and gait impairments Otago Exercise Program [24, 62, 63]: this home-based exercise program consists of resistance
training and balance training exercises; it will involve individualised prescription of exercise
in 5 home visits by a physiotherapist and monthly follow-up phone calls. Participants
will be encouraged to exercise 3 times a week (approximately 30 min each time) for 6 months.
Vision/sensation impairments 1. Review at Falls Clinic by a Consultant Geriatrician.
2. Onward referral to neurologist/ophthalmologist/optometrist if indicated.
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A cost-effectiveness acceptability curve will be plotted. A
cost-effectiveness acceptability curve provides informa-
tion about the probability that an intervention is cost-
effective, given a decision makers’ willingness to pay for
each additional QALY.
Discussion
This trial is expected to improve our understanding of diz-
ziness by identifying the main contributory causes of this
prevalent and debilitating condition in a representative
sample of older people. We also hope to demonstrate the
efficacy of conducting a comprehensive assessment
followed by a tailored multifaceted intervention in redu-
cing dizziness symptoms, improving associated impair-
ments to balance and gait and enhancing quality of life in
older people with self-reported dizziness symptoms. If
successful, the findings of this trial could be readily trans-
lated into clinical practice. The trial also has the capacity
to drive the implementation of a profile-based assessment
and intervention based on empirical data from quantita-
tive tests that best identify dizziness subtypes.
The outcomes of this study may have important impli-
cations, not only for the older population, but also for
the general population suffering with dizziness, as it is
documented that two percent of adults seek medical at-
tention annually for a new symptom of moderate to se-
vere dizziness or vertigo [34]. Unintended consequences
resulting from a sub-optimal assessment of dizziness in-
clude multiple referrals to specialists, abandonment of
social activities, loss of independence, increased sick
leave and job loss, depression and anxiety, falls and con-
cern about falls [1–4, 34, 35]. A validated and multifa-
ceted dizziness profile assessment complemented by
evidence-based therapies has the potential to improve
individual quality of life across all ages and clinician
quality of care, as well as reduce health care and com-
munity costs.
Conclusions
This study will determine the impact of a comprehensive
assessment followed by a tailored multifaceted interven-
tion in reducing dizziness episodes and symptoms, im-
proving associated impairments to balance and gait and
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